![ISPOR Europe 2024 – May 5-8. Register now.]({"type":"image" , "src" : "/sda/112342/JournalAd-ISPOR-2024-Leaderboard.jpg"})
Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Cynthia Matossian, William Trattler & Jennifer Loh. (2021) Dry Eye Treatment with Topical Cyclosporine 0.1% in Chondroitin Sulfate Ophthalmic Emulsion. Clinical Ophthalmology 15, pages 1979-1984.
Read now
Read now
Evelina Marinova, Dimitar Dabov & Yani Zdravkov. (2020) Ophthalmic complaints in face-mask wearing: prevalence, treatment, and prevention with a potential protective effect against SARS-CoV-2. Biotechnology & Biotechnological Equipment 34:1, pages 1323-1335.
Read now
Read now
Rodrigo Carlos de Oliveira & Steven E Wilson. (2019) Practical guidance for the use of cyclosporine ophthalmic solutions in the management of dry eye disease. Clinical Ophthalmology 13, pages 1115-1122.
Read now
Read now
Tatiana Deveney & Penny A Asbell. (2018) Patient and physician perspectives on the use of cyclosporine ophthalmic emulsion 0.05% for the management of chronic dry eye. Clinical Ophthalmology 12, pages 569-576.
Read now
Read now
Michelle K Rhee & Francis S Mah. (2017) Clinical utility of cyclosporine (CsA) ophthalmic emulsion 0.05% for symptomatic relief in people with chronic dry eye: a review of the literature. Clinical Ophthalmology 11, pages 1157-1166.
Read now
Read now
Nariman Nassiri, Yasaira Rodriguez Torres, Zachary Meyer, Michael A. Beyer, Gautham Vellaichamy, Amar S. Dhaliwal, Neil Chungfat & Frank S. Hwang. (2017) Current and emerging therapy of dry eye disease. Part A: pharmacological modalities. Expert Review of Ophthalmology 12:4, pages 269-297.
Read now
Read now
Articles from other publishers (32)
David Wirta, Patrick Vollmer, James Paauw, Kuei-Hsun Chiu, Eugenia Henry, Kristen Striffler, Jeffrey Nau, David Wirta, Jay Rubin, Charles Reilly, Lance Bergstrom, Karl Olsen, Gary Jerkins, Guruprasad Pattar, Bruce Segal, Carol Aune, John Goosey, Joel Geffin, Daniel Terveen, Kenneth Kenyon, Jung Dao, Kenneth Kenyon, Jared Peterson, Daniel Zimmer, Patrick Vollmer, Blair Boehmer, James Paauw, Yen Nieman & Eva Liang. (2022) Efficacy and Safety of OC-01 (Varenicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye Disease. Ophthalmology 129:4, pages 379-387.
Crossref
Crossref
Gemma Kim, Tae K. Kim & Luanne Carlson. 2022. Family Medicine. Family Medicine
967
982
.
Jason ElenbergerBohan KimAlexander de Castro-AbegerTonia S. Rex. (2020) Connections between intrinsically photosensitive retinal ganglion cells and TBI symptoms. Neurology 95:18, pages 826-833.
Crossref
Crossref
M. Cuneyt Ozmen, Gabriela Dieckmann, Stephanie M. Cox, Ramy Rashad, Rumzah Paracha, Nedda Sanayei, Melina I. Morkin & Pedram Hamrah. (2020) Efficacy and tolerability of nortriptyline in the management of neuropathic corneal pain. The Ocular Surface 18:4, pages 814-820.
Crossref
Crossref
Takashi Kojima, Murat Dogru, Motoko Kawashima, Shigeru Nakamura & Kazuo Tsubota. (2020) Advances in the diagnosis and treatment of dry eye. Progress in Retinal and Eye Research 78, pages 100842.
Crossref
Crossref
Gemma Kim, Tae K. Kim & Luanne Carlson. 2020. Family Medicine. Family Medicine
1
16
.
Monika Farhangi, William Feuer, Anat Galor, Didier Bouhassira, Roy C. Levitt, Constantine D. Sarantopoulos & Elizabeth R. Felix. (2019) Modification of the Neuropathic Pain Symptom Inventory for use in eye pain (NPSI-Eye). Pain 160:7, pages 1541-1550.
Crossref
Crossref
Charity J. Lee, Roy C. Levitt, Elizabeth R. Felix, Constantine D. Sarantopoulos & Anat Galor. (2017) Evidence that dry eye is a comorbid pain condition in a U.S. veteran population. PAIN Reports 2:6, pages e629.
Crossref
Crossref
Wan Chen, Hatim Ismail M. Batawi, Jimmy R. Alava, Anat Galor, Jin Yuan, Constantine D. Sarantopoulos, Allison L. McClellan, William J. Feuer, Roy C. Levitt & Jianhua Wang. (2017) Bulbar conjunctival microvascular responses in dry eye. The Ocular Surface 15:2, pages 193-201.
Crossref
Crossref
Alexandra E Levitt, Anat Galor, Aneesa R Chowdhury, Elizabeth R Felix, Constantine D Sarantopoulos, Gerald Y Zhuang, Dennis Patin, William Maixner, Shad B Smith, Eden R Martin & Roy C Levitt. (2017) Evidence that dry eye represents a chronic overlapping pain condition. Molecular Pain 13, pages 174480691772930.
Crossref
Crossref
Philippe Daull, Laurence Feraille, Stefano Barabino, Nicolas Cimbolini, Sophie Antonelli, Virgine Mauro & Jean-Sébastien Garrigue. (2016) Efficacy of a new topical cationic emulsion of cyclosporine A on dry eye clinical signs in an experimental mouse model of dry eye. Experimental Eye Research 153, pages 159-164.
Crossref
Crossref
Morgane Straub, Alain M Bron, Aurore Muselier-Mathieu & Catherine Creuzot-Garcher. (2016) Long-term outcome after topical ciclosporin in severe dry eye disease with a 10-year follow-up. British Journal of Ophthalmology 100:11, pages 1547-1550.
Crossref
Crossref
Nisreen S. Ezuddin, Karam A. Alawa & Anat Galor. (2015) Therapeutic Strategies to Treat Dry Eye in an Aging Population. Drugs & Aging 32:7, pages 505-513.
Crossref
Crossref
Heidi Crayton, Matthew Sidovar, Stanley Wulf & Amy Guo. (2014) Patient Perspectives and Experience with Dalfampridine Treatment in Multiple Sclerosis-Related Walking Impairment: The Step Together Program. The Patient - Patient-Centered Outcomes Research 8:3, pages 283-291.
Crossref
Crossref
Philip Ames & Anat Galor. (2015) Cyclosporine ophthalmic emulsions for the treatment of dry eye: a review of the clinical evidence. Clinical Investigation 5:3, pages 267-285.
Crossref
Crossref
Pradeep G. Sune, Mona Sune, Ruchi V. Mishra & Praveen K. Tidke. (2011) Role of Topical Cyclosporine “A” in Recurrent Adenoviral Keratitis and Dry Eyes. Highlights of Ophthalmology 39:2ENG, pages 2-5.
Crossref
Crossref
Yong-Soo ByunChang Rae RhoKyungjin ChoJin A ChoiKyung Sun NaChoun-Ki Joo. (2011) Cyclosporine 0.05% Ophthalmic Emulsion for Dry Eye in Korea: A Prospective, Multicenter, Open-Label, Surveillance Study. Korean Journal of Ophthalmology 25:6, pages 369.
Crossref
Crossref
Bora Yüksel, Berkant Bozdağ, Memed Acar & Engin TopaloğLu. (2018) Evaluation of the Effect of Topical Cyclosporine a with Impression Cytology in Dry Eye Patients. European Journal of Ophthalmology 20:4, pages 675-679.
Crossref
Crossref
Neil J Friedman. (2010) Impact of dry eye disease and treatment on quality of life. Current Opinion in Ophthalmology 21:4, pages 310-316.
Crossref
Crossref
Eric D. Donnenfeld, Renée Solomon, Calvin W. Roberts, John R. Wittpenn, Marguerite B. McDonald & Henry D. Perry. (2010) Cyclosporine 0.05% to improve visual outcomes after multifocal intraocular lens implantation. Journal of Cataract and Refractive Surgery 36:7, pages 1095-1100.
Crossref
Crossref
Claudio VitaliGianluigi Palombi & Pierluigi Cataleta. (2010) Treating Sjögren’s syndrome: insights for the clinician. Therapeutic Advances in Musculoskeletal Disease 2:3, pages 155-166.
Crossref
Crossref
Seung-Hyun LeeJun-Sung LeeIn-Cheon YouYeong-Geol ParkKyung-Chul Yoon. (2010) Study of Utilization Pattern and Compliance with Topical 0.05% Cyclosporine Emulsion in Korean Dry Eye Patients. Chonnam Medical Journal 46:2, pages 105.
Crossref
Crossref
Erin McCabe & Srihari Narayanan. (2009) Advancements in anti-inflammatory therapy for dry eye syndrome. Optometry - Journal of the American Optometric Association 80:10, pages 555-566.
Crossref
Crossref
Aikaterini Thanou-Stavraki & Judith A. James. (2008) Primary Sjogren’s Syndrome: Current and Prospective Therapies. Seminars in Arthritis and Rheumatism 37:5, pages 273-292.
Crossref
Crossref
Ivan Cher. (2008) A New Look at Lubrication of the Ocular Surface: Fluid Mechanics Behind the Blinking Eyelids. The Ocular Surface 6:2, pages 79-86.
Crossref
Crossref
Yeo-Jue ByunTae-Im KimKyung Yul Seo. (2008) The Short-Term Effect of Topical Cyclosporine A 0.05% in Various Ocular Surface Disorder. Journal of the Korean Ophthalmological Society 49:3, pages 401.
Crossref
Crossref
Jan D. Hirsch, Candis Morello, Renu Singh & Shira L. Robbins. (2007) Pharmacoeconomics of New Medications for Common Chronic Ophthalmic Diseases. Survey of Ophthalmology 52:6, pages 618-633.
Crossref
Crossref
Joon Young Hyon, Yun Jong Lee & Pil-Young Yun. (2007) Management of Ocular Surface Inflammation in Sjögren Syndrome. Cornea 26:Supplement 1, pages S13-S15.
Crossref
Crossref
Karl G Stonecipher & Parke T Green. (2007) Non-contact Confocal Microscopy of the Tear Film in Unoperated Eyes. Journal of Refractive Surgery 23:4, pages 417-419.
Crossref
Crossref
Shivaram Selvam, Padmaja B. Thomas, Melvin D. Trousdale, Douglas Stevenson, Joel E. Schechter, Austin K. Mircheff, Jean T. Jacob, Ronald E. Smith & Samuel C. Yiu. (2007) Tissue-engineered tear secretory system: Functional lacrimal gland acinar cells cultured on matrix protein-coated substrata. Journal of Biomedical Materials Research Part B: Applied Biomaterials 80B:1, pages 192-200.
Crossref
Crossref
William Trattler, Douglas Katsev & Donna Kerney. (2006) Self-reported compliance with topical cyclosporine emulsion 0.05% and onset of the effects of increased tear production as assessed through patient surveys. Clinical Therapeutics 28:11, pages 1848-1856.
Crossref
Crossref
Shivaram Selvam, Padmaja B. Thomas & Samuel C. Yiu. (2006) Tissue Engineering: Current and Future Approaches to Ocular Surface Reconstruction. The Ocular Surface 4:3, pages 120-136.
Crossref
Crossref